Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238432 · ClinicalTrials.gov registry record
The Genetics of Severe Asthma in Children
A clinical trial, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 193
- Enrollment target
NCT01238432 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 193 participants.
The verdict
NCT01238432 has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 193 participants
- Enrollment target
Study Summary
Near fatal asthma exacerbations are one of the most common causes of critical illness in children, accounting for approximately ten thousand intensive care unit (ICU) admissions per year in the United States. Even children with intermittent or mild baseline asthma can develop these severe exacerbations; however, there are few studies evaluating the risk factors associated with the development of near fatal asthma exacerbations in children. Inhaled β2-adrenergic receptor (ADRβ2) agonist therapy is the foundation of therapy for acute asthma and genetic variations of this receptor have been shown to affect response to ADRβ2 agonist therapy in this population. The investigators hypothesis is that a child's ADRβ2 genotype is associated with the development of a near fatal asthma exacerbation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2009-10 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01238432
The ClinicalTrials.gov registry entry for NCT01238432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01238432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01238432 about?
NCT01238432 is a clinical study titled "The Genetics of Severe Asthma in Children". Near fatal asthma exacerbations are one of the most common causes of critical illness in children, accounting for approximately ten thousand intensive care unit (ICU) admissions per year in the United States. Even children with intermittent or mild baseline asthma can develop these severe exacerbati...
What is the current status of trial NCT01238432?
This trial is currently completed. The enrollment target is 193 participants. The study started on 2009-10. Estimated completion is 2018-04.
Who is sponsoring clinical trial NCT01238432?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.